Clinical Research
Copyright ©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Nov 21, 2006; 12(43): 6992-6997
Published online Nov 21, 2006. doi: 10.3748/wjg.v12.i43.6992
Table 1 Baseline clinical, demographic, and imaging-based tumor characteristics of the enrolled patients (mean ± SD)
CharacteristicsTACE + LT group (n = 36)LT group (n = 21)P
Age (yr)49 ± 8.252 ± 8.00.13
Sex (M/F)31/518/30.99
Etiology of liver disease0.12
HBV34 (94.4%)18 (85.7%)
HCV0 (0%)2 (9.5%)
HBV + HCV1 (2.8%)0 (0%)
Alcoholic0 (0%)1 (4.8%)
α-fetoprotein (µg/L)193 ± 4721012 ± 41100.24
TACE
112 (33.3%)-
216 (44.4%)-
≥ 38 (22.2%)-
MELD score19 ± 922 ± 90.10
Type of graft
Cadaveric graft8 (22.2%)2 (9.5%)0.30
Living graft28 (77.8%)19 (90.5%)
Number of nodules
1/2/324/6/618/2/10.26
Diameter of the largest tumor (cm)0.10
Mean ± SD2.0 ± 0.62.3 ± 0.9
Range0.9-4.01.0-4.0
Sum of the tumor diameters (cm)0.38
Mean ± SD2.5 ± 1.12.8 ± 1.3
Range (cm)0.9-6.11.0-5.9